The US FDA has published the final Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format rule

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1418, 2003-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Following a review of four published observational studies, the US FDA has issued a statement

By  

Reactions Weekly, Vol. 1, Iss. 1335, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

A US federal judge has overruled the FDA 1998 paediatric drug testing rule

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 387, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

The Logistical Requirements of Current FDA Review: Format of Documentation Requested

By Hattan D.  

Regulatory Toxicology and Pharmacology, Vol. 24, Iss. 3, 1996-12 ,pp. : 232-235

Academic Press

Access to resources Recommend Favorite

Initiative to tackle counterfeit drugs announced by US FDA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

By Peters Eric J   Motsinger-Reif Alison   Havener Tammy M   Everitt Lorraine   Hardison Nicholas E   Watson Venita G   Wagner Michael   Richards Kristy L   Province Mike A   McLeod Howard L  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1407-1415

Future Medicine

Access to resources Recommend Favorite